SCHEDULE 13G/A

BioMarin Pharmaceutical Inc

Common Stock, par value $0.001 per share · CUSIP: 09061G101

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• VIKING GLOBAL INVESTORS LP

  Shares: 8,322,179 · Class: 4.3%

• VIKING GLOBAL PERFORMANCE LLC

  Shares: 5,397,003 · Class: 2.8%

• Viking Global Equities II LP

  Shares: 107,937 · Class: 0.1%

• Viking Global Equities Master Ltd.

  Shares: 5,289,066 · Class: 2.8%

• Viking Long Fund GP LLC

  Shares: 2,094,037 · Class: 1.1%

• Viking Long Fund Master Ltd.

  Shares: 2,094,037 · Class: 1.1%

• Viking Global Opportunities Parent GP LLC

  Shares: 831,139 · Class: 0.4%

• Viking Global Opportunities GP LLC

  Shares: 831,139 · Class: 0.4%

• Viking Global Opportunities Portfolio GP LLC

  Shares: 831,139 · Class: 0.4%

• Viking Global Opportunities Liquid Portfolio Sub-Master LP

  Shares: 831,139 · Class: 0.4%

• HALVORSEN OLE ANDREAS

  Shares: 8,322,179 · Class: 4.3%

• Ott David C.

  Shares: 8,322,179 · Class: 4.3%

• Shabet Rose Sharon

  Shares: 8,322,179 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.